Bruker Corporation (BRKRP) Stock Price & Analysis
Bruker Corporation (BRKRP) — price $421.44 (+0.23%), as of the Oct 23, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Bruker Corporation · BRKRP
Bruker Corporation develops and manufactures advanced scientific instruments and analytical systems for molecular and materials research, serving diverse sectors globally. The company's specialized tools empower detailed analysis across life sciences, industrial applications, and critical infrastructure.
Price as of Oct 23, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $421.44 | |
| Change on the day | +0.23% | |
| 52-week range | $264.30 – $484.90 | |
| Shares traded on the day | 670 |
Price & events
Watch the BRKRP film — every key number, told as a short cinematic story
~2 min · open the film
What is Bruker (BRKRP), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Bruker Corporation (BRKRP) is the company analyzed here. It employs 11,085 people and is led by Frank H. Laukien. In Q2 FY2026 it reported revenue of $839M and net income of -$52M.
What do the latest results show for Bruker (BRKRP)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $839M. Against analyst estimates the company has EPS beat 5 of 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $839M | -$52M | -$0.41 (diluted) |
| Q1 FY2026 | $823M | $14M | $0.02 (diluted) |
| Q4 FY2025 | $977M | $26M | $0.10 (diluted) |
| Q3 FY2025 | $861M | -$60M | -$0.41 (diluted) |
What are the financial strengths and risks for Bruker (BRKRP)?
Short answer · as of
The distress and quality screens read Altman Z 2.30 · Piotroski F 5. Trailing ratios: ROE -2.9% · ROA -1.2% · current ratio 1.85 · earnings yield -0.8% · free-cash-flow yield 1.1%.
What has been published about Bruker (BRKRP)?
Bruker Stock: Key Questions Answered
These answers are editorial: 1 of these 1 answer is drawn from the BRKRP research dossier (written Jun 15, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
What are the primary operational segments of Bruker Corporation and their focus areas?
Bruker Corporation operates through several key segments, each with distinct focus areas. The Bruker Scientific Instruments (BSI) BioSpin segment concentrates on life science tools utilizing magnetic resonance technology, primarily for structural biology and preclinical imaging.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (13 figures)
The 13 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 7 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $421.44 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-26T09:24:42.993Z. | |
px.change | Change on the day | +0.23% | FMP | Financial Modeling Prep (FMP) · quote | |
px.change_abs | Change on the day, in dollars | +$0.955 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 670 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $839M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q2 FY2026 | -$52M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed |
UNRECORDED — 6 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.range52 | 52-week range | $264.30 – $484.90 | UNRECORDED | Stored company-profile observation — Captured 2026-10-25 | |
id.employees | Employees | 11,085 | UNRECORDED | Stored company-profile observation — Captured 2026-10-25 | |
id.ceo | Chief executive | Frank H. Laukien | UNRECORDED | Stored company-profile observation — Captured 2026-10-25 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 5 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-25 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 2.30 · Piotroski F 5 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-07 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE -2.9% · ROA -1.2% · current ratio 1.85 · earnings yield -0.8% · free-cash-flow yield 1.1% | UNRECORDED | Stored key metrics — Captured 2026-10-25 · Expired observation |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.